Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
eClerx Services Ltd, Bajaj Finserv Ltd, Marico Ltd, Force Motors Ltd are among the other stocks to see a surge in volumes on BSE today, 28 January 2026.
J B Chemicals & Pharmaceuticals Ltd recorded volume of 2.11 lakh shares by 10:46 IST on BSE, a 62.37 times surge over two-week average daily volume of 3382 shares. The stock lost 1.29% to Rs.1,857.00. Volumes stood at 2097 shares in the last session.
eClerx Services Ltd registered volume of 2.11 lakh shares by 10:46 IST on BSE, a 34.71 fold spurt over two-week average daily volume of 6080 shares. The stock slipped 0.07% to Rs.4,401.80. Volumes stood at 2896 shares in the last session.
Bajaj Finserv Ltd notched up volume of 20.44 lakh shares by 10:46 IST on BSE, a 22.17 fold spurt over two-week average daily volume of 92220 shares. The stock rose 0.82% to Rs.1,931.40. Volumes stood at 63797 shares in the last session.
Marico Ltd witnessed volume of 4.93 lakh shares by 10:46 IST on BSE, a 15.15 times surge over two-week average daily volume of 32546 shares. The stock dropped 3.03% to Rs.723.30. Volumes stood at 36396 shares in the last session.
Force Motors Ltd registered volume of 87933 shares by 10:46 IST on BSE, a 10.69 fold spurt over two-week average daily volume of 8227 shares. The stock rose 0.25% to Rs.18,845.00. Volumes stood at 14290 shares in the last session.
In Q3 FY26, operating EBITDA stood at Rs 305 crore, up 12.96%, compared with Rs 270 crore posted in the same quarter last year. Operating EBITDA margin stood at 28.7% in Q3 FY26 as against 28.1% in Q3 FY25.
Nikhil Chopra, CEO and whole-time director of JB Pharma, stated, “JB Pharma’s domestic formulations business once again outperformed the Indian pharmaceutical market, driven by broad-based momentum across key chronic therapies and continued strength in our flagship brands. On the international front, while the CDMO business continued its positive momentum, the international formulations business also recorded strong growth in several key markets.
Our focus on cost optimization, favorable product mix, and operational efficiencies led to improved operating margins for Q3 FY26 as well as for 9M FY26. With a strong balance sheet, net cash position, and sustained cash flow generation, we remain confident in our ability to deliver profitable growth. As we move forward, our priorities remain centered on strengthening flagship brand franchises, accelerating growth in chronic therapies, scaling our CDMO businesses, and building a resilient, agile, and future-ready organization.”
JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radiodiagnostics, APIs, and intermediates.
J B Chemicals & Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 1925.9, up 1.15% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 25522.15. The Sensex is at 83010.66, down 0.67%. J B Chemicals & Pharmaceuticals Ltd has risen around 6.57% in last one month.
Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has risen around 3.29% in last one month and is currently quoting at 22217.05, down 0.2% on the day. The volume in the stock stood at 1.11 lakh shares today, compared to the daily average of 1.71 lakh shares in last one month.
The PE of the stock is 42.28 based on TTM earnings ending September 25.